Skip to main content
Dr. Lal Pathlabs Limited logo

Dr. Lal Pathlabs Limited — Investor Relations & Filings

Ticker · LALPATHLAB ISIN · INE600L01024 LEI · 984500E8E9CY102B9718 BSE.NS Human health and social work activities
Open in API
Filings indexed 1,098 across all filing types
Latest filing 2018-10-01 Call Transcript
Country IN India
Listing BSE.NS LALPATHLAB

About Dr. Lal Pathlabs Limited

https://www.lalpathlabs.com/

Dr. Lal Pathlabs Limited is a provider of diagnostic and related healthcare tests and services. The company offers a comprehensive range of clinical laboratory tests and profiles used for prediction, early detection, diagnostic screening, confirmation, and monitoring of diseases. Its service portfolio encompasses pathology, including biochemistry, hematology, clinical pathology, histopathology, and molecular diagnostics, as well as radiology services such as X-ray, ultrasound, and CT scans. The organization operates an extensive network of laboratories, patient service centers, and pick-up points, utilizing advanced automated systems and standardized processes. Key offerings include specialized wellness packages and home sample collection. The company maintains high quality standards through international and national accreditations, serving a diverse patient base and healthcare providers with a focus on accuracy and timely reporting.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 70% confidence The document text is extremely short (289 characters) and appears to be a brief schedule or summary of a meeting or conference call involving an analyst and an institutional investor. It mentions a date and a one-on-one meeting type, with a reference to a conference call. There is no substantive financial data, no detailed report content, and no indication of a full transcript. Given the nature of the content, it is most consistent with a Call Transcript (CT) or possibly a meeting schedule related to a call. However, since it does not contain a full transcript but rather a meeting summary or schedule, it aligns best with a Call Transcript category as it relates to conference calls. Confidence is moderate due to limited content but the context points to a call-related document.
2018-10-01 English
Trading Window
Regulatory Filings Classification · 100% confidence The document text is essentially empty, containing only placeholder lines and a note about an omitted picture. There is no substantive content, no mention of any report type, regulatory body, fiscal period, or any financial or corporate information. Given the lack of content, this cannot be classified as any specific report or announcement. It fits best as a Regulatory Filing (RNS) by default, as a fallback category for miscellaneous or empty filings.
2018-09-28 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 80% confidence The document is extremely short (398 characters) and appears to be a brief note or record of a one-on-one meeting with an analyst from CLSA on September 18, 2018, in Gurugram. There is no substantive financial data, no report content, no regulatory references, or detailed discussion. It does not contain any financial statements, earnings data, or formal report material. It is not an announcement of a report either, but rather a meeting note or transcript snippet. Given the nature of the content, it best fits the category of a Call Transcript (CT), as it records a meeting with an analyst, which is typical for transcripts or summaries of investor calls or meetings.
2018-09-18 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice informing stock exchanges about the schedule of upcoming analyst and institutional investor meetings. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events. The content is an announcement of meetings, not a financial report, earnings release, or detailed presentation. The document length is only 1562 characters, indicating it is a brief announcement rather than a full report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2018-09-17 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 90% confidence The document contains a schedule or list of meetings with analysts and institutional investors, including dates, names, venues, and types of meetings. There is no financial data, no report content, no voting results, no management changes, or any other regulatory or financial disclosure. The document is very short (477 characters) and appears to be a meeting schedule or summary rather than a formal report or announcement. It does not fit into any specific report category such as Annual Report, Earnings Release, or Investor Presentation. Given the nature of the content, the best fitting category is Regulatory Filings (RNS) as a general miscellaneous filing that does not fit other categories.
2018-09-12 English
Updates
Regulatory Filings
2018-09-11 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.